About Allergan - U.S. Dermatology Portfolio
Allergan (NYSE: AGN), fka Actavis and before that Watson Pharmaceuticals, is a global pharmaceutical company focused on developing, manufacturing, and commercializing innovative branded pharmaceuticals, high-quality generic, and over-the-counter medicines and biologic products for patients around the world. Allergan markets a portfolio of products that provide treatments for the central nervous system, eye care, medical aesthetics, gastroenterology, women's health, urology, cardiovascular, and anti-infective therapeutic categories. Actavis is also engaged in research and development. Watson Pharmaceuticals took on the name Actavis after its 2012 acquisition of the Swiss drug maker of the same name; Actavis later took on the name Allergan after its 2015 acquisition of the American health care company of the same name.